Diagnosing Death using Neurological Criteria
The Academy of Medical Royal College has published an update to its 2008 Code of Practice for the Diagnosis and Confirmation of Death. The updated version is available on the Academy of Medical Royal College website.
The change over to the updated 2025 Code will occur on the 1 January 2025.
UNTIL 1 JANUARY 2025, FOLLOW THE 2008 CODE.
UNTIL 1 JANUARY 2025, USE THE CURRENT TESTING FORMS.
- Form for the Diagnosis of Death using Neurological Criteria - Long Version (2021)
- Form for the Diagnosis of Death using Neurological Criteria - Short Version (2021)
2025 UPDATE: Code of Practice for the Diagnosis and Confirmation of Death
The 2025 update from the Academy accounts for advances in medical practice and technologies, particularly in the fields of resuscitation, intensive care, neurosurgery and organ donation.
Additionally, the 2025 Code incorporates lessons learnt from individual clinical cases in both adult and paediatric practice in the UK and internationally. For this reason the eight 'red flag' patient groups, which were present on the endorsed testing forms, but not in the 2008 Code, have now been fully incorporated and described in more detail in the 2025 Code.
The Academy is very clear that the updated 2025 Code does not represent any alteration in the validity of historic diagnoses of death. It is entirely best medical practice to update a 17-year-old Code of Practice.
Of benefit, the update aligns the UK, where possible, to the growing world-wide medical consensus in diagnosing death. The update was particularly influenced by:
- The 2020 work of the World Brain Death Project.
- The 2021 Australian and New Zealand Intensive Care Society's Statement on Death and Organ Donation.
- The multiple evidence-based publications in the 2023 Canadian Journal of Anesthesia Special Issue: Defining and Determining Death in Canada.
- The 2023 Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline from the American Academy of Neurology and the American Academy of Pediatrics.
Finally the 2025 Code incorporates updated guidance from the Royal College of Paediatrics and Child Health (RCPCH) which supersedes their 2015 recommendations for the Diagnosis of death by neurological criteria in infants less than two months old, and their 1991 report for children older than two months, Diagnosis of brain-stem death in infants and children: a working party report of the British Paediatric Association (which was reproduced in the 2008 Code, Appendix 4). This means that the 2025 Code will be applicable for all ages.
Important updates in the 2025 Code
< 37 weeks DNC cannot be confidently made.
37 weeks – 2 years Criteria is the same as per adults, with 3 caveats:
- 24 hrs before testing
- 24 hrs between testing
- No ancillary investigation.
2 years and above Criteria as per adults.
This was a pragmatic decision by the RCPCH working group, taking together all the available evidence, combined with a desire to align more closely to international guidance, and without intending to cast doubt on any previous diagnosis of death.
Start PaCO2 ≥ 5.3 KPa
End PaCO2 ≥ 8.0 kPa, pH < 7.3 + Rise PaCO2 ≥ 2.7 kPa
Time Minimum 5 minutes
The working group had no safety concerns with the current UK apnoea test as outlined in the 2008 Code. However, the updated 2025 Code apnoea test will more closely align the UK to international practice. Particularly the requirement for end arterial blood gas targets (PaCO2 ≥ 8.0 kPa, pH < 7.3) and including a rise of PaCO2 ≥ 2.7 kPa (20 mmHg). Additionally the same apnoea test can now be used across all age groups, which previously wasn’t the case for the under 2 months of age.
It was accepted that with the new lower starting PaCO2 (≥ 5.3 kPa) compared to the previous 2008 Code (≥ 6.0 kPa), some doctors may choose to delay taking the confirmatory arterial blood gas sample immediately at 5 minutes, to increase the certainty that the PaCO2 and pH have reached the apnoea end arterial blood targets. The 5 minutes observation is a minimum.
Completion of the second set of clinical tests. If ancillary investigations are required to confirm death, and are carried out after clinical testing, the time of death will be the point at which the result of the ancillary investigation is available to the final two doctors in Test 2.
This update more closely aligns the UK to international practice, reflects the evolving recommendation for two mandated sets of clinical tests of brainstem function (2008 and 2025 Code), fits with the 2025 Code general recommendation to time death to when the healthcare professionals are satisfied all the relevant criteria to diagnose death are met, and may be more supportive of families who increasingly witness the second set of tests and often want to be with their loved one at the recorded time of death.
To date, the courts have ordinarily deferred to healthcare professionals to provide a time of death. The legal experts in the Academy working group could see no reason a change to timing death to the point when the healthcare professionals are satisfied all the relevant criteria to diagnose death are met, rather than retrospectively timing death to the conclusion of the first set of tests, would not be equally supported.
The foreword to the 2025 Code is signed by all four Chief Medical officers across the UK.
Support from the National Medical Examiner for England and Wales has been gained.
The Coronial services of England and Wales, and Northern Ireland were consulted and voiced no disagreement.
The Crown Office and Procurator Fiscal service in Scotland was consulted and voiced no disagreement.
The core temperature should be greater than or equal to 36°C at the time of clinical testing.
In patients who are hypothermic (defined as a core temperature less than 36°C), either therapeutic or accidental, a minimum 24 hour observation period is required following correction of hypothermia (that is, attaining a core temperature of 36°C or greater). Following correction of hypothermia, transient and temporary reductions in temperature do not mandate a further 24 hour observation at normothermia.
The core temperature should be greater than or equal to 36°C at the time of clinical testing.
In the case of an inability to examine both eyes or both ears, for whatever reason, ancillary investigation will be required.
Given that the eyes are required in the clinical testing of three of the six brainstem reflexes used in neurological criteria, it is recommended that it must be possible to examine both eyes and there should be no reason to suspect an eye injury or abnormality would prevent the reflex occurring if it could. In the case of an inability to examine either eye, for whatever reason, it was recommended that ancillary investigation would be required to support a diagnosis of death using neurological criteria. Similarly, both ears must be able to be accessed for the vestibulo-ocular reflex.
This change aligns the UK to other international guidance.
As an intensivist what do you need to do and know?
1. Please familiarise yourself with the updated 2025 Code.
2. Please prepare yourself, so that from the 1 January 2025 you will only use the updated intensive care professionally endorsed Testing Form.
- Blue form - For use in adults and children older than 2-years
- Yellow form - For use in infants between 37-weeks to 2-years, corrected gestational age.
- There is no longer a short or long form.
- From the 1st January 2025 please remove all older versions of the form from your ICU.
3. Please make use of the education materials listed below.
- 2025 AoMRC Code - Key Updates to DNC
- AoMRC Code 2025 Update Summary
- DNC Testing Form Draft 2.1 (PDF)
- The NHS Blood and Transplant website also has additional resource and educational videos available on this topic.
Forms and Guidance
The lay perspective
Ms Pauline Elliot, FICM Board Lay Representative, patient representative on the AoMRC group rewriting the guidance, and member of PatientVoices@RCoA, has authored a blog for the RCoA website (published December 2024) on the update.
Pauline underlines the AoMRC group's desire to ensure that all deaths are diagnosed and confirmed in an accurate, standardised and timely manner.